By Mukhtar Yahya Usman

Antimicrobial resistance (AMR) is one of the most pressing public health challenges of our time.

Defined as the ability of microorganisms—such as bacteria, viruses, fungi, and parasites—to resist the effects of medications that once successfully treated infections, AMR poses a severe threat to global health, food security, and development.

Understanding Antimicrobial Resistance

Dr. Yahya Usman Umar, the Head of the Department of Microbiology at Aminu Kano Teaching Hospital Kano, explains that antimicrobial resistance occurs when bacteria or other microorganisms evolve and adapt in ways that render antibiotics and other antimicrobial agents ineffective.

“This evolution is accelerated by the misuse and overuse of these drugs in humans, animals, and agriculture,” Dr. Umar states.

“When microorganisms become resistant, standard treatments become ineffective, leading to prolonged illnesses, higher medical costs, and an increased risk of death.”

The Danger of Antimicrobial Resistance

The dangers of AMR cannot be overstated. According to Dr. Umar, infections caused by resistant microorganisms are more difficult to treat, and they often require more expensive and toxic alternatives.

“The consequences of untreated or poorly treated infections can lead to severe complications and, in some cases, fatalities,” he warns.

“Moreover, the spread of resistant strains can trigger outbreaks, making AMR a significant concern for public health globally and in Nigeria.”

In Kano and other regions, AMR is exacerbated by several factors, including the widespread availability of antibiotics without prescriptions, improper dosages, and lack of awareness among the public about the dangers of self-medication.

“We are witnessing a scenario where common infections, such as urinary tract infections or respiratory diseases, are becoming increasingly difficult to treat due to resistant bacteria,” Dr. Umar notes.

Why Antimicrobial Resistance is a Public Health Threat

AMR’s status as a public health threat stems from its potential to undermine decades of progress in medicine.

“Without effective antimicrobials, the success of major surgeries, cancer chemotherapy, and organ transplants is jeopardized,” Dr. Umar explains.

“These procedures rely on the ability to control infections, and if our medications fail, the risks associated with these treatments increase dramatically.”

Dr. Umar also highlights that AMR can lead to longer hospital stays, a need for more intensive care, and a greater burden on healthcare systems already strained by other public health challenges.

“In low-resource settings like Kano, the impact of AMR could be catastrophic, as access to alternative treatments is often limited,” he adds.

The Way Forward: Combating Antimicrobial Resistance

Addressing the threat of AMR requires a multifaceted approach. Dr. Umar emphasizes the importance of strengthening antibiotic stewardship programs, which promote the appropriate use of antimicrobials.

“Healthcare professionals need to be trained on the judicious prescription of antibiotics, and the public must be educated on the dangers of self-medication and the importance of completing prescribed courses of treatment,” he suggests.

Dr. Umar also calls for improved infection prevention and control measures, both in healthcare settings and in the community.

“Reducing the spread of resistant infections can be achieved through better hygiene practices, vaccination, and the use of diagnostics to guide treatment decisions,” he explains.

Moreover, Dr. Umar advocates for increased investment in research and development to discover new antibiotics and alternative therapies.

“Given the slow pace of new drug development, we must also explore innovative strategies, such as bacteriophage therapy and the use of probiotics, to combat resistant infections,” he recommends.

Dr. Umar stresses that combating antimicrobial resistance is not just the responsibility of healthcare professionals but requires collective action from policymakers, the public, and global health organizations.

“We must work together to preserve the efficacy of our current treatments and ensure a safer future for all,” he concludes.

This special report is brought to you by Premier Radio in partnership with the Media EIS Fellowship